IBDEI0OU ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25023,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25023,1,3,0)
 ;;=3^Hallucinogen Intoxication Delirium w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,25023,1,4,0)
 ;;=4^F16.121
 ;;^UTILITY(U,$J,358.3,25023,2)
 ;;=^5003325
 ;;^UTILITY(U,$J,358.3,25024,0)
 ;;=F16.221^^95^1177^11
 ;;^UTILITY(U,$J,358.3,25024,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25024,1,3,0)
 ;;=3^Hallucinogen Intoxication Delirium w/ Mod/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,25024,1,4,0)
 ;;=4^F16.221
 ;;^UTILITY(U,$J,358.3,25024,2)
 ;;=^5003339
 ;;^UTILITY(U,$J,358.3,25025,0)
 ;;=F16.921^^95^1177^12
 ;;^UTILITY(U,$J,358.3,25025,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25025,1,3,0)
 ;;=3^Hallucinogen Intoxication Delirium w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,25025,1,4,0)
 ;;=4^F16.921
 ;;^UTILITY(U,$J,358.3,25025,2)
 ;;=^5003351
 ;;^UTILITY(U,$J,358.3,25026,0)
 ;;=F16.129^^95^1177^13
 ;;^UTILITY(U,$J,358.3,25026,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25026,1,3,0)
 ;;=3^Hallucinogen Intoxication w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,25026,1,4,0)
 ;;=4^F16.129
 ;;^UTILITY(U,$J,358.3,25026,2)
 ;;=^5003327
 ;;^UTILITY(U,$J,358.3,25027,0)
 ;;=F16.229^^95^1177^14
 ;;^UTILITY(U,$J,358.3,25027,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25027,1,3,0)
 ;;=3^Hallucinogen Intoxication w/ Mod/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,25027,1,4,0)
 ;;=4^F16.229
 ;;^UTILITY(U,$J,358.3,25027,2)
 ;;=^5003340
 ;;^UTILITY(U,$J,358.3,25028,0)
 ;;=F16.929^^95^1177^15
 ;;^UTILITY(U,$J,358.3,25028,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25028,1,3,0)
 ;;=3^Hallucinogen Intoxication w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,25028,1,4,0)
 ;;=4^F16.929
 ;;^UTILITY(U,$J,358.3,25028,2)
 ;;=^5003352
 ;;^UTILITY(U,$J,358.3,25029,0)
 ;;=F16.180^^95^1177^1
 ;;^UTILITY(U,$J,358.3,25029,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25029,1,3,0)
 ;;=3^Hallucinogen Induced Anxiety Disorder w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,25029,1,4,0)
 ;;=4^F16.180
 ;;^UTILITY(U,$J,358.3,25029,2)
 ;;=^5003332
 ;;^UTILITY(U,$J,358.3,25030,0)
 ;;=F16.280^^95^1177^2
 ;;^UTILITY(U,$J,358.3,25030,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25030,1,3,0)
 ;;=3^Hallucinogen Induced Anxiety Disorder w/ Mod/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,25030,1,4,0)
 ;;=4^F16.280
 ;;^UTILITY(U,$J,358.3,25030,2)
 ;;=^5003345
 ;;^UTILITY(U,$J,358.3,25031,0)
 ;;=F16.980^^95^1177^3
 ;;^UTILITY(U,$J,358.3,25031,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25031,1,3,0)
 ;;=3^Hallucinogen Induced Anxiety Disorder w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,25031,1,4,0)
 ;;=4^F16.980
 ;;^UTILITY(U,$J,358.3,25031,2)
 ;;=^5003357
 ;;^UTILITY(U,$J,358.3,25032,0)
 ;;=F16.14^^95^1177^4
 ;;^UTILITY(U,$J,358.3,25032,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25032,1,3,0)
 ;;=3^Hallucinogen Induced Bipolar Disorder w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,25032,1,4,0)
 ;;=4^F16.14
 ;;^UTILITY(U,$J,358.3,25032,2)
 ;;=^5003328
 ;;^UTILITY(U,$J,358.3,25033,0)
 ;;=F16.24^^95^1177^5
 ;;^UTILITY(U,$J,358.3,25033,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25033,1,3,0)
 ;;=3^Hallucinogen Induced Bipolar Disorder w/ Mod/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,25033,1,4,0)
 ;;=4^F16.24
 ;;^UTILITY(U,$J,358.3,25033,2)
 ;;=^5003341
 ;;^UTILITY(U,$J,358.3,25034,0)
 ;;=F16.94^^95^1177^6
 ;;^UTILITY(U,$J,358.3,25034,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25034,1,3,0)
 ;;=3^Hallucinogen Induced Bipolar Disorder w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,25034,1,4,0)
 ;;=4^F16.94
 ;;^UTILITY(U,$J,358.3,25034,2)
 ;;=^5003353
 ;;^UTILITY(U,$J,358.3,25035,0)
 ;;=F16.159^^95^1177^7
 ;;^UTILITY(U,$J,358.3,25035,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25035,1,3,0)
 ;;=3^Hallucinogen Induced Psychotic Disorder w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,25035,1,4,0)
 ;;=4^F16.159
 ;;^UTILITY(U,$J,358.3,25035,2)
 ;;=^5003331
 ;;^UTILITY(U,$J,358.3,25036,0)
 ;;=F16.259^^95^1177^8
 ;;^UTILITY(U,$J,358.3,25036,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25036,1,3,0)
 ;;=3^Hallucinogen Induced Psychotic Disorder w/ Mod/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,25036,1,4,0)
 ;;=4^F16.259
 ;;^UTILITY(U,$J,358.3,25036,2)
 ;;=^5003344
 ;;^UTILITY(U,$J,358.3,25037,0)
 ;;=F16.959^^95^1177^9
 ;;^UTILITY(U,$J,358.3,25037,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25037,1,3,0)
 ;;=3^Hallucinogen Induced Psychotic Disorder w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,25037,1,4,0)
 ;;=4^F16.959
 ;;^UTILITY(U,$J,358.3,25037,2)
 ;;=^5003356
 ;;^UTILITY(U,$J,358.3,25038,0)
 ;;=F16.99^^95^1177^38
 ;;^UTILITY(U,$J,358.3,25038,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25038,1,3,0)
 ;;=3^Phencyclidine Use Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,25038,1,4,0)
 ;;=4^F16.99
 ;;^UTILITY(U,$J,358.3,25038,2)
 ;;=^5133359
 ;;^UTILITY(U,$J,358.3,25039,0)
 ;;=F16.983^^95^1177^16
 ;;^UTILITY(U,$J,358.3,25039,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25039,1,3,0)
 ;;=3^Hallucinogen Persisting Perception Disorder
 ;;^UTILITY(U,$J,358.3,25039,1,4,0)
 ;;=4^F16.983
 ;;^UTILITY(U,$J,358.3,25039,2)
 ;;=^5003358
 ;;^UTILITY(U,$J,358.3,25040,0)
 ;;=F16.20^^95^1177^37
 ;;^UTILITY(U,$J,358.3,25040,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25040,1,3,0)
 ;;=3^Phencyclidine Use Disorder,Severe
 ;;^UTILITY(U,$J,358.3,25040,1,4,0)
 ;;=4^F16.20
 ;;^UTILITY(U,$J,358.3,25040,2)
 ;;=^5003336
 ;;^UTILITY(U,$J,358.3,25041,0)
 ;;=F16.180^^95^1177^17
 ;;^UTILITY(U,$J,358.3,25041,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25041,1,3,0)
 ;;=3^Phencyclidine Induced Anxiety Disorder w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,25041,1,4,0)
 ;;=4^F16.180
 ;;^UTILITY(U,$J,358.3,25041,2)
 ;;=^5003332
 ;;^UTILITY(U,$J,358.3,25042,0)
 ;;=F16.280^^95^1177^18
 ;;^UTILITY(U,$J,358.3,25042,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25042,1,3,0)
 ;;=3^Phencyclidine Induced Anxiety Disorder w/ Moderate/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,25042,1,4,0)
 ;;=4^F16.280
 ;;^UTILITY(U,$J,358.3,25042,2)
 ;;=^5003345
 ;;^UTILITY(U,$J,358.3,25043,0)
 ;;=F16.980^^95^1177^19
 ;;^UTILITY(U,$J,358.3,25043,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25043,1,3,0)
 ;;=3^Phencyclidine Induced Anxiety Disorder w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,25043,1,4,0)
 ;;=4^F16.980
 ;;^UTILITY(U,$J,358.3,25043,2)
 ;;=^5003357
 ;;^UTILITY(U,$J,358.3,25044,0)
 ;;=F16.14^^95^1177^20
 ;;^UTILITY(U,$J,358.3,25044,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25044,1,3,0)
 ;;=3^Phencyclidine Induced Bipolar & Related Disorder w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,25044,1,4,0)
 ;;=4^F16.14
 ;;^UTILITY(U,$J,358.3,25044,2)
 ;;=^5003328
 ;;^UTILITY(U,$J,358.3,25045,0)
 ;;=F16.24^^95^1177^21
 ;;^UTILITY(U,$J,358.3,25045,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25045,1,3,0)
 ;;=3^Phencyclidine Induced Bipolar & Related Disorder w/ Moderate/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,25045,1,4,0)
 ;;=4^F16.24
 ;;^UTILITY(U,$J,358.3,25045,2)
 ;;=^5003341
 ;;^UTILITY(U,$J,358.3,25046,0)
 ;;=F16.94^^95^1177^22
 ;;^UTILITY(U,$J,358.3,25046,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25046,1,3,0)
 ;;=3^Phencyclidine Induced Bipolar & Related Disorder w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,25046,1,4,0)
 ;;=4^F16.94
 ;;^UTILITY(U,$J,358.3,25046,2)
 ;;=^5003353
 ;;^UTILITY(U,$J,358.3,25047,0)
 ;;=F16.14^^95^1177^23
 ;;^UTILITY(U,$J,358.3,25047,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25047,1,3,0)
 ;;=3^Phencyclidine Induced Depressive Disorder w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,25047,1,4,0)
 ;;=4^F16.14
 ;;^UTILITY(U,$J,358.3,25047,2)
 ;;=^5003328
 ;;^UTILITY(U,$J,358.3,25048,0)
 ;;=F16.24^^95^1177^24
 ;;^UTILITY(U,$J,358.3,25048,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25048,1,3,0)
 ;;=3^Phencyclidine Induced Depressive Disorder w/ Moderate/Severe Use Disorder
